COFCO Biotechnology Co., Ltd.

SZSE:000930 Stock Report

Market Cap: CN¥8.4b

COFCO Biotechnology Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Manyi Wang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure4.3yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Analysis Article • Feb 24

COFCO Biotechnology Co., Ltd.'s (SZSE:000930) Prospects Need A Boost To Lift Shares

With a price-to-sales (or "P/S") ratio of 0.5x COFCO Biotechnology Co., Ltd. ( SZSE:000930 ) may be sending bullish...
Analysis Article • Jan 07

COFCO Biotechnology (SZSE:000930) Is Making Moderate Use Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Oct 14

COFCO Biotechnology Co., Ltd. (SZSE:000930) Surges 39% Yet Its Low P/S Is No Reason For Excitement

COFCO Biotechnology Co., Ltd. ( SZSE:000930 ) shareholders would be excited to see that the share price has had a great...
Analysis Article • Sep 30

We Think COFCO Biotechnology (SZSE:000930) Has A Fair Chunk Of Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Jul 17

COFCO Biotechnology Co., Ltd. (SZSE:000930) Looks Inexpensive But Perhaps Not Attractive Enough

With a price-to-sales (or "P/S") ratio of 0.5x COFCO Biotechnology Co., Ltd. ( SZSE:000930 ) may be sending bullish...
Analysis Article • Jun 03

COFCO Biotechnology (SZSE:000930) Is Carrying A Fair Bit Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Apr 17

Returns On Capital Signal Tricky Times Ahead For COFCO Biotechnology (SZSE:000930)

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
Analysis Article • Mar 07

COFCO Biotechnology Co., Ltd.'s (SZSE:000930) Price Is Right But Growth Is Lacking

COFCO Biotechnology Co., Ltd.'s ( SZSE:000930 ) price-to-sales (or "P/S") ratio of 0.6x might make it look like a buy...

CEO

Manyi Wang

no data
Tenure

Manyi Wang is General Manager of COFCO Biotechnology Co. Ltd.

Leadership Team

NamePositionTenureCompensationOwnership
Changping Hu
Chief Accountant & Financial Manager6yrsCN¥761.90kno data
Xichun Pan
Board Secretary6.9yrsCN¥695.10k0.0070%
CN¥ 586.2k
Rui Qiao
Deputy General Manager2.6yrsCN¥840.20kno data
Manyi Wang
General Managerno datano datano data
Jinbo Su
Board Secretaryno datano datano data
Shao Hui Chen
Deputy General Manager2yrsno datano data
4.3yrs
Average Tenure
54.5yo
Average Age

Experienced Management: 000930's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Guojin Jiang
Chairman of the Board2.3yrsCN¥841.90kno data
Hongfei Zhang
Director2.5yrsCN¥496.30kno data
Guoqiang Chen
Independent Director4.9yrsCN¥120.00kno data
Zhi Li
Employee Supervisor6.8yrsno datano data
Laichun Wang
Chairman of the Supervisory Board3.2yrsno datano data
Heshan Zheng
Director2.4yrsno datano data
Nianchun Zhang
Independent Director2.4yrsCN¥103.40kno data
Yanrui Gao
Employee Supervisor3.1yrsno datano data
Ping Wang
Independent Director1.8yrsCN¥30.00kno data
2.5yrs
Average Tenure
54yo
Average Age

Experienced Board: 000930's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/19 02:41
End of Day Share Price 2026/07/17 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

COFCO Biotechnology Co., Ltd. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xia ShengCitic Securities Co., Ltd.
Wei LiuHaitong International Research Limited
Jiao ChenIndustrial Securities Co. Ltd.